�������ýҕ�l

Eli Lilly & Co. has notched another victory in the obesity drug wars. The latest Phase 3 study for Mounjaro shows the drug is effective in helping people with diabetes lose a substantial amount of weight. (Lisa Jarvis, 4/27)

Unlike most things in the House Republicans’ debt-limit bill — such as those across-the-board spending cuts — there is one measure that might secure widespread support: adding work requirements to Medicaid. In past surveys, even a significant share of Democratic voters appeared amenable to the idea. (Catherine Rampell, 4/27)

The story of ADHD in America today is a window into how our fractured health-care delivery system — and hyper-connected culture — can make people feel simultaneously better and worse. (Kate Woodsome, 4/27)

The Food and Drug Administration recently amended its authorizations for Pfizer and Moderna’s mRNA vaccines, prompting the Centers for Disease Control and Prevention to modify its COVID-19 vaccine recommendations. (Saad B. Omer, 4/28)

We understand now that the word “hospice” means more than just care for the last few days of life. My mother-in-law needed to be released from the futile round of hospitalization followed by rehab followed by more hospitalization. She wasn’t yet actively dying, but she was no longer fixable. (Joan Wickersham, 4/28)

A data-driven interactive tool launched earlier this year in Dallas County can predict the risk of asthma in children and is already yielding some results. (4/28)

More than 400 Americans undergo major amputation of a leg, either above or below the knee, every day. Many of them suffer from what’s known as chronic limb-threatening ischemia (CLTI), a form of peripheral artery disease that narrows people’s arteries. (Mehdi Shishehbor, 4/28)